JENNIFER POTERBIN: Open Payments
NPI 1093192619 · WEST NYACK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,523 in 123 payments from 16 companies in 2025. Trend: 2023 $2,529 · 2024 $2,868 · 2025 $3,523
Food & beverage: $3,423Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $789 |
| Janssen Biotech, Inc. | 14 | $747 |
| Madrigal Pharmaceuticals | 15 | $511 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $263 |
| GENZYME CORPORATION | 4 | $220 |
| QOL Medical, LLC | 3 | $196 |
| Intercept Pharmaceuticals, Inc. | 6 | $193 |
| Ardelyx, Inc. | 8 | $140 |
| Gilead Sciences, Inc. | 5 | $102 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $92 |
Products named: TREMFYA, REZDIFFRA, RINVOQ, SKYRIZI, DUPIXENT, ENTYVIO, Sucraid, OCALIVA.
Industry payments across NY — which companies pay providers there.
